Queuine Analogues Incorporating the 7-Aminomethyl-7-deazaguanine Core: Structure-Activity Relationships in the Treatment of Experimental Autoimmune Encephalomyelitis

ChemMedChem. 2023 Sep 1;18(17):e202300207. doi: 10.1002/cmdc.202300207. Epub 2023 Jul 21.

Abstract

A library of queuine analogues targeting the modification of tRNA isoacceptors for Asp, Asn, His and Tyr catalysed by queuine tRNA ribosyltransferase (QTRT, also known as TGT) was evaluated in the treatment of a chronic multiple sclerosis model: murine experimental autoimmune encephalomyelitis. Several active 7-deazaguanines emerged, together with a structure-activity relationship involving the necessity for a flexible alkyl chain of fixed length.

Keywords: RNA modifications; experimental autoimmune encephalomyelitis; multiple sclerosis; queuine; transfer RNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Encephalomyelitis, Autoimmune, Experimental* / drug therapy
  • Mice
  • Pentosyltransferases / metabolism
  • RNA, Transfer
  • Structure-Activity Relationship

Substances

  • 7-deazaguanine
  • queuine
  • RNA, Transfer
  • Pentosyltransferases